Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers October 15, 2018
Pharmacy Choice - News - Over-the-Counter Drugs - October 15, 2018

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 24 of 24     Go To Page:

10/15/18 - Cinclus Pharma abstract selected Poster of Excellence at the UEGW conference
The Basel, Switzerland- based biotech company Cinclus Pharma AG today announced that its abstract P1152 was selected Poster of Excellence at the upcoming United European Gastroenterology Week, which is the largest annual meeting in Europe focused on GI-related diseases. The poster presentation will be given by Kjell Andersson, CEO at Cinclus Pharma
10/15/18 - Headline goes here gily gily The People's Pharmacy: Will vitamin D solve the SAD problem?
QUESTION: During a cold winter, I began to feel more sad than usual, as well as fuzzy, forgetful and achy. This worried me enough to send me to the doctor. People in Northern states might have difficulty getting enough vitamin D. The National Health and Nutrition Examination Survey showed that 29 percent of Americans were deficient in vitamin D and
10/15/18 - Innovus Pharma Receives Approval from Amazon to Expand its Amazon Stores to Japan
Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men s and women's health and respiratory diseases, today announced the approval from Amazon for the expansion of its Amazon stores to Japan.
10/12/18 - ACETO CORP - 10-Q/A - Management's Discussion and Analysis of Financial Condition and Results of Operations
CAUTIONARY STATEMENT RELATING TO THE SAFE HARBOR PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 This Quarterly Report contains forward-looking statements as that term is defined in the federal securities laws. The events described in forward-looking statements contained in this Quarterly Report may not occur.
10/12/18 - Active Pharmaceutical Ingredients Industry Sales, Supply And Consumption 2018 Analysis And Forecasts To 2026
Active Pharmaceutical Ingredients- Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2026. Wiseguyreports.Com Adds "Active Pharmaceutical Ingredients- Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2026" To Its Research Database. Global Active Pharmaceutical Ingredients Market is accoun
10/12/18 - Active Pharmaceutical Ingredients Market 2018 Global Share, Trend And Opportunities Forecast To 2026
Active Pharmaceutical Ingredients Industry Description Wiseguyreports.Com Adds "Active Pharmaceutical Ingredients -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2026" To Its Research Database Glob...
10/12/18 - Hundreds of health, weight loss products contain unapproved ingredients: ...
Researchers found 746 over-the-counter supplements contained potentially harmful and undeclared ingredients not approved by the U.S. Food and Drug Administration. The study analyzed data from a tainted supplements database maintained by the FDA for trends in adulterated dietary supplements associated with a warning by the FDA. Although two-thirds o
10/12/18 - Pharmaceutical Packaging Market Worth Over $94 Billion in 2018 Says Visiongain Report
Visiongain, a independent media company, issued the following news:. Visiongain's new report Pharmaceutical Packaging Market Report 2018-2028: Global Forecasts by Material, by Product and by Delivery System Plus Profiles of Leading Companies and Leading National Market Analysis indicates that the pharmaceutical packaging market will see over $94 bn
10/11/18 - CVS Merger with Insurer Aetna Greenlighted
Washington Antitrust officials gave CVS the green light on Wednesday to purchase Aetna, the nation s third-largest health insurance company, in a $69 billion deal that could potentially transform the health care industry and change how millions of Americans receive basic medical services. But in trying to head off the worst cases, CVS and Aet
10/11/18 - FDA Approves Stiolto Respimat Supplemental New Drug Application (sNDA) to Add Data on COPD Exacerbation Reduction
Boehringer Ingelheim announced today that the U.S. Food and Drug Administration approved new labeling for Stiolto Respimat Inhalation Spray that includes data showing a meaningful reduction in COPD exacerbations driven by tiotropium, which is the active ingredient in Spiriva Respimat Inhalation Spray. Stiolto Respimat is a combination medicine th
10/11/18 - Global ePharmacy Market Analysis, Growth By Top Companies, Trends By Types And Application, Forecast To 2025
ePharmacy Market or internet pharmacy, commonly called as ePharmacy, is a method of enabling the online purchase of medicines. It offers the convenience to its customers in purchasing and delivering products, providing valuable information on the pre...
10/11/18 - OTC Drugs Market Opportunity Analysis - an Infiniti Research Case Study on the Pharmaceutical Drugs Industry
A global market and customer intelligence solutions provider, Infiniti Research, has announced the completion of their latest market opportunity analysis for a pharmaceutical company. OTC drugs market opportunity analysis- an Infiniti Research case study on the pharmaceutical drugs industry. The OTC drugs market in countries such as India, China, a
10/11/18 - Rising Biosciences Receives FDA Clearance for TSW Pain Cream; Expedites Testing of CBD Only Variants of Cannophen and TSW Pain Cream Products [T-break Tech (Middle East)]
The past 30 days have been very exciting for our industry, states Rising Biosciences COO Arthur Hall. As well, on October 17th, 2018, Marijuana becomes legal in Canada as a result of The Cannabis Act, passed on June 3rd, 2018, marking Canada as the first G7 country to legalize Marijuana. Rising Biosciences has decided to seek registration as a fore
10/11/18 - U.S. FDA Approves XARELTO (rivaroxaban) to Reduce the Risk of Major Cardiovascular Events in Patients with Chronic Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD)
The Janssen Pharmaceutical Companies of Johnson& Johnson announced today that the U.S. Food and Drug Administration has approved XARELTO to reduce the risk of major cardiovascular events, such as CV death, myocardial infarction and stroke, in people with chronic coronary or peripheral artery disease. "Despite the use of guideline-recommended
10/10/18 - Acura Pharmaceuticals, Inc. Restructures Debt Obligations [Sudan Tribune]
-Acura Pharmaceuticals, Inc., a specialty pharmaceutical company focused on innovating abuse deterrent drugs, today announced that on October 5, 2018 we restructured our debt obligations by receiving an additional $1.8 million loan from John Schutte and retiring in full our senior secured debt with Oxford Finance for a payment of $1.5 million.
10/10/18 - AfroCentric takes over Activo
Investment company s acquisition of remaining stake in drug importer allows it to take on pharmaceutical giants Financial& Business WriterAfroCentric, the owner of Medscheme and Pharmaceutical Direct, is positioning itself to compete with pharmaceutical giants after announcing on Tuesday that it had agreed to acquire a further 74% st
10/10/18 - Akorn, Inc. (NASDAQ:AKRX) Files An 8-K Regulation FD Disclosure
Akorn, Inc. (NASDAQ:AKRX) Files An 8-K Regulation FD DisclosureItem 7.01. Regulation FD Disclosure. On October 10, 2018, Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, announced that it has received a new Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for Bimatopros
10/10/18 - NUTRA PHARMA CORP. (OTCMKTS:NPHC) Files An 8-K Changes in Registrant's Certifying Accountant
NUTRA PHARMA CORP. (OTCMKTS:NPHC) Files An 8-K Changes in Registrant's Certifying AccountantITEM 4.01Changes in Registrant's Certifying Accountant. (a)Prior independent registered public accounting firm On October3, 2018, the Audit Committee of the Board of Directors (the Committee) of Nutra Pharma Corp. (the Company) received a let
10/10/18 - Rising Biosciences Receives FDA Clearance for TSW Pain Cream; Expedites Testing of CBD Only Variants of Cannophen? and TSW Pain Cream Products
The past 30 days have been very exciting for our industry, states Rising Biosciences COO Arthur Hall. On September 21 st, we completed our FDA testing on TSW, and last week, the DEA moved to place certain FDA approved CBD drugs down from Schedule I to Schedule V. It is the first time the agency has lowered any type of cannabis from Schedul
10/9/18 - Acura Pharmaceuticals, Inc. Restructures Debt Obligations
Acura Pharmaceuticals, Inc., a specialty pharmaceutical company focused on innovating abuse deterrent drugs, today announced that on October 5, 2018 we restructured our debt obligations by receiving an additional $1.8 million loan from John Schutte and retiring in full our senior secured debt with Oxford Finance for a payment of $1.5 million.
10/9/18 - Adamas Presents Final Results from the Two-Year, Phase 3 Open-Label Study of GOCOVRI in Parkinsons Disease Patients with Dyskinesia [Sudan Tribune]
-Adamas Pharmaceuticals, Inc., a fully integrated pharmaceutical company pioneering time-dependent medicines for central nervous system disorders, today announced the presentation of final results from EASE LID 2, the companys two-year Phase 3 open-label study of GOCOVRI extended release capsules, the first and only medicine approved by the U.S. Fo
10/9/18 - Bose wins FDA green light for first OTC hearing aid [Tehran Times (Iran)]
Though users may fit, program and control the hearing aid on their own, the Framingham, Massachusetts- based Bose must comply with applicable federal and state laws regarding the sale of hearing aids, including state laws that might require hearing aids to be purchased from or dispensed by a licensed hearing aid dispenser, the FDA said. The FDA is
10/8/18 - Dr. Greg Grillo of Grillo Robeck Dental Files a Petition with the Food and Drug Administration Requesting Regulation of Dangerously Acidic Oral Moisturizers
Greg Grillo recently filed a petition with the Food and Drug Administration requesting to regulate the manufacturing of dangerously acidic oral moisturizers currently sold over the counter in the US. The recent studies prompted Dr. Grillo to initiate the petition aimed at increasing awareness of the troubling issue. In addition to the FDA filing, D
10/8/18 - Libtayo (cemiplimab-rwlc) Data at ESMO 2018 Congress Provide New Insights in Six Tumor Types Under Investigation
TARRYTOWN, N.Y. and PARIS, Oct. 8, 2018/ PRNewswire/ Regeneron Pharmaceuticals, Inc. and Sanofi will present a diverse set of data from their joint clinical program investigating Libtayo at the ESMO 2018 Congress from October 19 to 23 in Munich, Germany. "Following the U.S. FDA approval of Libtayo in advanced CSCC, we remain focused on pursui
Articles(s): 1 - 24 of 24     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415